NOV 04, 2023
Updates in Retinoblastoma
Dr. Swathi Kaliki, MD, panelist for the Retinablastoma session of Ocular Oncology/Pathology Subspecialty Day, and Dr. Lauren Dalvin, discuss the current status of retinoblastoma around the world, from new diagnostic advances using AI to the promise of intracameral chemotherapy treatment.
Financial Disclosures: Dr. Lauren Dalvin discloses financial relationships with the Leonard and Mary Lou Hoeft Career Development Award Fund, National Cancer Institute, and National Center for Advancing Translational Science (Grant Support). Dr. Swathi Kaliki discloses no financial relationships.